TELA Bio, Inc. (TELA) Net margin 2017–2025
TELA Bio, Inc. (TELA) net profit margin by fiscal year — reported net income divided by reported revenue.
-48.4%FY2025 · since FY2017: -502.6% → -48.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -48.4% | +6.2 pp |
| FY2024 | -54.6% | +25.2 pp |
| FY2023 | -79.8% | +27.1 pp |
| FY2022 | -106.9% | +6.0 pp |
| FY2021 | -112.9% | +45.2 pp |
| FY2020 | -158.1% | -12.9 pp |
| FY2019 | -145.2% | +109.7 pp |
| FY2018 | -254.9% | +247.6 pp |
| FY2017 | -502.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Gross profitTELA Gross marginTELA Operating incomeTELA Operating marginTELA Operating cash flowTELA Free cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →